News · Approval
1,552 stories
Jul 29, 26FDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute
Jul 29, 26Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
Jul 29, 26Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more
Jul 28, 26Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn
Jul 28, 26The future of gray-market peptides